Escitalopram oxalate and Dermatitis - a phase IV clinical study of FDA data

Summary:

Dermatitis is reported as a side effect among people who take Escitalopram oxalate (escitalopram oxalate), especially for people who are female, 60+ old, also take Dupixent, and have Crohn's disease.

The phase IV clinical study analyzes which people have Dermatitis when taking Escitalopram oxalate. It is created by eHealthMe based on reports of 17,508 people who have side effects when taking Escitalopram oxalate from the FDA, and is updated regularly.

What is Escitalopram oxalate?

Escitalopram oxalate has active ingredients of escitalopram oxalate. It is often used in depression. eHealthMe is studying from 17,930 Escitalopram oxalate users. Check the latest studies of Escitalopram oxalate.

What is Dermatitis?

Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it) is found to be associated with 1,551 drugs and 1,231 conditions by eHealthMe. Check the latest studies of Dermatitis.

On Jul, 12, 2026

17,508 people reported to have side effects when taking Escitalopram oxalate.
Among them, 23 people (0.13%) have Dermatitis.

Could Escitalopram oxalate cause Dermatitis?

Among these 23 people:

What is the gender of people who have Dermatitis when taking Escitalopram oxalate? *

female: 86.96 %
male: 13.04 %

What is the age of people who have Dermatitis when taking Escitalopram oxalate? *

What are other drugs people take besides Escitalopram oxalate? *

Dupixent: 8 people, 34.78%
Hydroxychloroquine Sulfate: 6 people, 26.09%
Cyanocobalamin: 6 people, 26.09%
Prednisone: 5 people, 21.74%
Omeprazole: 5 people, 21.74%
Vitamin D3: 5 people, 21.74%
Levothyroxine Sodium: 5 people, 21.74%
Gabapentin: 5 people, 21.74%
Atorvastatin Calcium: 5 people, 21.74%
Folic Acid: 5 people, 21.74%

What are other side effects people have besides Dermatitis? *

Rashes (redness): 10 people, 43.48%
Itching: 8 people, 34.78%
Fatigue (feeling of tiredness): 6 people, 26.09%
Pain: 5 people, 21.74%
Skin Burning Sensation: 4 people, 17.39%
High Blood Pressure: 3 people, 13.04%
Swelling: 3 people, 13.04%
Psoriasis (immune-mediated disease that affects the skin): 3 people, 13.04%
Groin Pain: 3 people, 13.04%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 3 people, 13.04%

What are the existing conditions these people have? *

Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 5 people, 21.74%
Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 4 people, 17.39%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 4 people, 17.39%
Bronchitis Chronic (inflammation of the mucous membrane in the bronchial tubes- chronic): 4 people, 17.39%
Gastritis (inflammation of stomach): 4 people, 17.39%
Rickets (softening of bones): 4 people, 17.39%
Lupus-Like Syndrome (a disease symptom matches with lupus an immune disease): 4 people, 17.39%
Iron Deficiency Anaemia: 4 people, 17.39%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 3 people, 13.04%
High Blood Pressure: 3 people, 13.04%

* Approximation only. Some reports may have incomplete information.

Do you take Escitalopram oxalate and have Dermatitis?

- Check whether Dermatitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Escitalopram oxalate:

Escitalopram oxalate (17,930 reports)

Dermatitis treatments and more:

Dermatitis (30,577 reports)

Browse all side effects of Escitalopram oxalate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dermatitis:

Dermatitis (1,551 drugs)

Browse all the conditions that are associated with Dermatitis:

Dermatitis (1,231 conditions)

Related publications that referenced our studies

O’Brien FE, O’Connor RM, Clarke G, Donovan MD, Dinan TG, Griffin BT, Cryan JF, "The P-glycoprotein inhibitor cyclosporin A differentially influences behavioural and neurochemical responses to the antidepressant escitalopram", Behavioural brain research, 2014 Mar .
O’Brien FE, O’Connor RM, Clarke G, Donovan MD, Dinan TG, Griffin BT, Cryan JF, "The P-glycoprotein inhibitor cyclosporin A differentially influences behavioural and neurochemical responses to the antidepressant escitalopram", Behavioural brain research, 2014 Mar .

How the study uses the data?

The study uses data from the FDA. It is based on escitalopram oxalate (the active ingredients of Escitalopram oxalate) and Escitalopram oxalate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.